Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marie-Catherine Vozenin-Brotons is active.

Publication


Featured researches published by Marie-Catherine Vozenin-Brotons.


International Journal of Radiation Oncology Biology Physics | 2003

Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression

Marie-Catherine Vozenin-Brotons; Fabien Milliat; Jean-Christophe Sabourin; Anne-Charlotte de Gouville; Agnès François; Philipe Lasser; Philipe Morice; Christine Haie-Meder; Antoine Lusinchi; Sami Antoun; Jean Bourhis; Denis Mathé; Theo Girinsky; Jocelyne Aigueperse

PURPOSEnTo investigate the expression of a new fibrogenic cytokine the connective tissue growth factor (CTGF) in intestinal radiation fibrosis and to characterize the mesenchymal cell subtypes involved in CTGF synthesis and collagen deposition.nnnMETHODS AND MATERIALSnSixteen patients with radiation enteritis that occurred after radiotherapy for pelvic malignancies and 6 with histologically normal bowel entered the study. Immunohistochemistry, Western blot analysis, and real-time reverse transcriptase-polymerase chain reaction were performed to study CTGF expression, along with other known markers of radiation fibrosis: the pro-fibrogenic cytokine transforming growth factor (TGF)-beta1 and phenotypic markers of the fibroblast differentiation the alpha-sm actin (A), vimentin (V), and desmin (D). Finally, the collagen accumulation was measured by Sirius red staining and colorimetric assay.nnnRESULTSnRadiation enteritis was characterized by increased collagen content within the intestinal wall. CTGF immunoreactivity, protein, and mRNA level were increased in radiation enteritis compared with the healthy bowel. On the contrary, no increase of the TGF-beta1 mRNA level was observed in radiation enteritis compared with healthy bowel, and the level of TGF-beta protein was slightly increased in radiation enteritis. A co-localization of CTGF immunoreactivity and collagen deposition was found in the extracellular matrix and subtypes of activated mesenchymal cells with a fibroblast phenotype (V(+)/D(-)/A(-)) and myofibroblast phenotype (V(+)/D(-/+)/A(+)).nnnCONCLUSIONnThe increased level of CTGF protein and mRNA associated with the accumulation of fibroblasts/myofibroblasts and collagen deposition were parts of the fibrogenic signals involved in the persistence of late intestinal radiation fibrosis.


PLOS ONE | 2009

Novel Anti-Metastatic Action of Cidofovir Mediated by Inhibition of E6/E7, CXCR4 and Rho/ROCK Signaling in HPV+ Tumor Cells

Abdessamad Amine; Sofia Rivera; Paule Opolon; Mehdi Dekkal; Denis Biard; Hakim Bouamar; Fawzia Louache; Michael J. McKay; Jean Bourhis; Eric Deutsch; Marie-Catherine Vozenin-Brotons

Cervical cancer is frequently associated with HPV infection. The expression of E6 and E7 HPV oncoproteins is a key factor in its carcinogenicity and might also influence its virulence, including metastatic conversion. The cellular mechanisms involved in metastatic spread remain elusive, but pro-adhesive receptors and their ligands, such as SDF-1α and CXCR4 are implicated. In the present study, we assessed the possible relationship between SDF-1α/CXCR4 signaling, E6/E7 status and the metastatic process. We found that SDF-1α stimulated the invasion of E6/E7-positive cancer cell lines (HeLa and TC-1) in Matrigel though CXCR4 and subsequent Rho/ROCK activation. In pulmonary metastatic foci generated by TC-1 cells IV injection a high proportion of cells expressed membrane-associated CXCR4. In both cases models (in vitro and in vivo) cell adhesion and invasion was abrogated by CXCR4 immunological blockade supporting a contribution of SDF-1α/CXCR4 to the metastatic process. E6 and E7 silencing using stable knock-down and the approved anti-viral agent, Cidofovir decreased CXCR4 gene expression as well as both, constitutive and SDF-1α-induced cell invasion. In addition, Cidofovir inhibited lung metastasis (both adhesion and invasion) supporting contribution of E6 and E7 oncoproteins to the metastatic process. Finally, potential signals activated downstream SDF-1α/CXCR4 and involved in lung homing of E6/E7-expressing tumor cells were investigated. The contribution of the Rho/ROCK pathway was suggested by the inhibitory effect triggered by Cidofovir and further confirmed using Y-27632 (a small molecule ROCK inhibitor). These data suggest a novel and highly translatable therapeutic approach to cervix cancer, by inhibition of adhesion and invasion of circulating HPV-positive tumor cells, using Cidofovir and/or ROCK inhibition.


Scandinavian Journal of Gastroenterology | 2006

Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation

Carine Strup-Perrot; Marie-Catherine Vozenin-Brotons; Marie Vandamme; Marc Benderitter; Denis Mathé

Objective. Colonic response to single-dose irradiation is characterized by epithelial denudation followed by restitution. Extracellular matrix (ECM) remodeling is involved in both of these phases. The aim of this study was to characterize the contribution of matrix metalloproteinases (MMPs) and of their stimulatory and inhibitory pathways in radiation-induced ECM remodeling in colonic tissue. Material and methods. Rats were irradiated with single-dose 10 Gy X-rays to the abdomen. Activity, localization, and mRNA levels of MMPs and molecules involved in their activation and inhibition (plasmin/plasminogen; TIMPs), of inflammatory mediators (IL-1β, TNF-α) in the distal colon, 1, 3, and 7 days after irradiation were analyzed using a combination of approaches including zymography, immunohistochemistry, and real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Results. The main finding of this study is that radiation-induced alteration of the mucosal structure is concomitant with local increased expression and activation of MMP subtypes involved in basement membrane degradation (MMP-2, -3, and -9). We investigated MMP-2 activation pathways and found an early increase in mRNA levels of soluble inflammatory mediators (TNF-α and IL-1β). Furthermore, transcription and activity of MMP-2 activating molecules, such as MMP-14, and molecules involved in the plasminogen/plasmin system were found to increase during the denudation phase. Interestingly, induction of MMP inhibitors TIMP-1 and PAI-1 was observed during the restitution phase. MMP inhibitors may be able to stop acute wound healing response by inhibiting ECM degradation. Conclusions. This study brings new insights into ECM remodeling in the colon after exposure to ionizing radiation and highlights the role of MMP subtypes specialized in basement membrane degradation.


Radiotherapy and Oncology | 2005

Induction of CTGF by TGF-β1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives

Valérie Haydont; Denis Mathé; C. Bourgier; Jalil Abdelali; Jocelyne Aigueperse; Jean Bourhis; Marie-Catherine Vozenin-Brotons


International Journal of Radiation Oncology Biology Physics | 2007

Successful Mitigation of Delayed Intestinal Radiation Injury Using Pravastatin is not Associated with Acute Injury Improvement or Tumor Protection

Valérie Haydont; Olivier Gilliot; Sofia Rivera; C. Bourgier; Agnès François; Jocelyne Aigueperse; Jean Bourhis; Marie-Catherine Vozenin-Brotons


International Journal of Radiation Oncology Biology Physics | 2007

Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat.

Sandra Torres; Lars Thim; Fabien Milliat; Marie-Catherine Vozenin-Brotons; Ulfe Bang Olsen; Ian Ahnfelt-Rønne; Jean Bourhis; Marc Benderitter; Agnès François


Radiation Physics and Chemistry | 2005

Bowel injury associated with pelvic radiotherapy

Agnès François; Fabien Milliat; Marie-Catherine Vozenin-Brotons


Radiotherapy and Oncology | 2006

137 Treatment of radiation enteritis with pravastatin : Role of the rho pathway on CTGF expression

Valérie Haydont; C. Bourgier; A. Fransois; Antoine Lusinchi; M. Pocard; Jean Bourhis; Marie-Catherine Vozenin-Brotons


Radiotherapy and Oncology | 2011

567 speaker ANTIVIRAL APPROACHES TO TREAT HPV RELATED TUMORS : THE INSTITUTE GUSTAVE ROUSSY EXPERIENCE FROM PRE-CLINICAL DATA TO CLINICAL TRIALS

Eric Deutsch; Marie-Catherine Vozenin-Brotons; Philippe Morice; Catherine Lhommé; Patricia Pautier; M. Deberne; J.C. Soria; Christine Haie-Meder; Jean-Henri Bourhis


International Journal of Radiation Oncology Biology Physics | 2008

Are E6 and E7 Oncoproteins the Key Modulators of Radiosensitivity in HPV 16 and 18 Carcinoma Cell Lines

H.K. Lord; Dominique Violot; D. Biard; Jean Bourhis; Marie-Catherine Vozenin-Brotons; Eric Deutsch

Collaboration


Dive into the Marie-Catherine Vozenin-Brotons's collaboration.

Top Co-Authors

Avatar

Valérie Haydont

Institut de radioprotection et de sûreté nucléaire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Bourgier

Institut de radioprotection et de sûreté nucléaire

View shared research outputs
Top Co-Authors

Avatar

Agnès François

Institut de radioprotection et de sûreté nucléaire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Denis Mathé

Institut de radioprotection et de sûreté nucléaire

View shared research outputs
Top Co-Authors

Avatar

Fabien Milliat

Institut de radioprotection et de sûreté nucléaire

View shared research outputs
Top Co-Authors

Avatar

Jocelyne Aigueperse

Institut de radioprotection et de sûreté nucléaire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge